Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 7,400 | 7,539 | 4,945 | 5,055 | 4,635 |
| Cost of Goods | 3,779 | 4,562 | 2,486 | 2,163 | 3,306 |
| Gross Profit | 3,621 | 2,976 | 2,459 | 2,892 | 1,329 |
| Operating Expenses | 3,060 | 2,708 | 4,320 | 2,364 | 2,090 |
| Operating Income | 1,340 | 831 | -1,374 | 691 | -455 |
| Interest Expense | 80 | 79 | 72 | 95 | 92 |
| Other Income | 1,224 | -620 | 2,383 | -2,457 | -1,048 |
| Pre-tax Income | 2,484 | 131 | 936 | -1,861 | -1,594 |
| Income Tax | 3 | -946 | 4 | N/A | -2 |
| Net Income Continuous | 2,482 | 1,077 | 932 | -1,861 | -1,592 |
| Net Income | $2,482 | $1,077 | $936 | $-1,861 | $-1,596 |
| EBITDA(a) | $1,725 | $1,208 | $-715 | $974 | $-170 |